GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CanadaBis Capital Inc (TSXV:CANB) » Definitions » Forward Dividend Yield %

CanadaBis Capital (TSXV:CANB) Forward Dividend Yield % : 0.00% (As of Jun. 07, 2024)


View and export this data going back to 2017. Start your Free Trial

What is CanadaBis Capital Forward Dividend Yield %?

As of today (2024-06-07), the Forward Annual Dividend Yield of CanadaBis Capital is 0.00%.

As of today (2024-06-07), the Trailing Annual Dividend Yield of CanadaBis Capital is 0.00%.

TSXV:CANB's Forward Dividend Yield % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.945
* Ranked among companies with meaningful Forward Dividend Yield % only.

CanadaBis Capital's Dividends per Share for the three months ended in Jan. 2024 was C$0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of CanadaBis Capital's Forward Dividend Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, CanadaBis Capital's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CanadaBis Capital's Forward Dividend Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CanadaBis Capital's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where CanadaBis Capital's Forward Dividend Yield % falls into.



CanadaBis Capital Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.


CanadaBis Capital  (TSXV:CANB) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


CanadaBis Capital Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of CanadaBis Capital's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


CanadaBis Capital (TSXV:CANB) Business Description

Traded in Other Exchanges
Address
PO Box 850, Rocky Mountain House, AB, CAN, T4T 1A6
CanadaBis Capital Inc is a vertically-integrated cannabis company. The firm engages in the production and sale of recreational cannabis. Its product line consists of Stigma Roots. It operates in three segments: wholesale, retail, and extraction and tolling. The wholesale segment cultivates and distributes cannabis and cannabis products to and through, provincial liquor and cannabis boards. Retail segment involves sale of cannabis and cannabis-related products to end consumers on-premise owned and operated by the Company. Extraction and tolling segment provides cannabinoid extraction services to other licensed producers. The company generates maximum of its revenue from Extraction and tolling.
Executives
Garfield Richards Senior Officer

CanadaBis Capital (TSXV:CANB) Headlines

From GuruFocus

Four Cannabis Companies Capitalizing On Increased CBD Demand

By Marketwired Marketwired 08-18-2021